New Elite Feature: Chart Magnifying Glass

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

By Oculis Holding AG | June 03, 2025, 5:00 PM

Oculis Holding AG

ZUG, Switzerland, June 03, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.

Attachments

Mentioned In This Article

Oculis Holding AG

Latest News

Jun-15	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jun-11	Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026 OCS GlobeNewswire
Jun-10	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jun-09	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jun-09	Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease OCS GlobeNewswire
Jun-08	Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference OCS GlobeNewswire
May-29	OCS Stock Drops Over 23% Eye Drop Trial For Diabetic Vision Loss Misses Target OCS -36.09% OCS -23.42% Stocktwits
May-29	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS -36.09% OCS -23.42% GlobeNewswire
May-29	Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema OCS -23.42% GlobeNewswire
May-28	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
May-21	Etsy upgraded, ZoomInfo downgraded: Wall Street's top analyst calls OCS +11.07% The Fly
May-15	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS -7.33% OCS GlobeNewswire
May-14	Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors OCS GlobeNewswire
May-11	Oculis Reports Q1 2026 Financial Results and Provides Company Update OCS -6.86% OCS GlobeNewswire
May-07	Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial OCS +5.10% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)